Photo by prophet2018 from unsplash
Coronavirus disease 2019 (COVID-19) is an emerging global pandemic with severe morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Molnupiravir, an ester prodrug form of… Click to show full abstract
Coronavirus disease 2019 (COVID-19) is an emerging global pandemic with severe morbidity and mortality caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Molnupiravir, an ester prodrug form of N4-hydroxycytidine (NHC), was recently emergency-use approved for the treatment of early SARS-CoV-2 infections. Herein, we report the synthesis and evaluation of a series of novel NHC analogs.
Keywords:
novel hydrocytidine;
analogs potential;
hydrocytidine analogs;
synthesis novel;
sars cov;
potential anti
Journal Title: Pharmaceuticals
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pharmaceuticals
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!